GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer

Biochemical and Biophysical Research Communications

Volumn 451, Issue 1, 2014, Pages 74-78

  Tao, Sifeng ^a   He, Haifei ^a   Chen, Qiang ^a   Yue, Wenjie ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; Estrogen; G protein coupled estrogen receptor 1; HLA G; miR 148a

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; HLA G ANTIGEN; MICRORNA; MICRORNA 148A; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; MIRN148 MICRORNA, HUMAN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE EVASION; MCF 7 CELL LINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; BREAST TUMOR; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-G ANTIGENS; HUMANS; MCF-7 CELLS; MICRORNAS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84906226736     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.07.073     Document Type: Article

References (35)

1. T. Vargo-Gogola, and J.M. Rosen Modelling breast cancer: one size does not fit all Nat. Rev. Cancer 7 2007 659 672
2. J.D. Yager, and N.E. Davidson Estrogen carcinogenesis in breast cancer N. Engl. J. Med. 354 2006 270 282
3. E.A. Musgrove, and R.L. Sutherland Biological determinants of endocrine resistance in breast cancer Nat. Rev. Cancer 9 2009 631 643
4. L.V. Rhodes, C.R. Tate, H.C. Segar, H.E. Burks, T.B. Phamduy, V. Hoang, S. Elliott, D. Gilliam, F.N. Pounder, M. Anbalagan, D.B. Chrisey, B.G. Rowan, M.E. Burow, and B.M. Collins-Burow Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators Breast Cancer Res. Treat. 145 3 2014 593 604
5. N. Sakamoto, Y. Naito, N. Oue, K. Sentani, N. Uraoka, H. Zarni Oo, K. Yanagihara, K. Aoyagi, H. Sasaki, and W. Yasui MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis Cancer Sci. 105 2 2014 236 243
6. J. Xia, X. Guo, J. Yan, and K. Deng The role of miR-148a in gastric cancer J. Cancer Res. Clin. Oncol. 2014 [Epub ahead of print]
7. A. Lujambio, G.A. Calin, A. Villanueva, S. Ropero, M. Sanchez-Cespedes, and D. Blanco et al. A microRNA DNA methylation signature for human cancer metastasis Proc. Natl. Acad. Sci. USA 105 2008 13556 13561
8. Z. Chen, T. Ma, C. Huang, L. Zhang, T. Xu, T. Hu, and J. Li MicroRNA-148a: a potential therapeutic target for cancer Gene 533 1 2014 456 457
9. J. Yu, Q. Li, Q. Xu, L. Liu, and B. Jiang MiR-148a inhibits angiogenesis by targeting ERBB3 J. Biomed. Res. 25 3 2011 170 177
10. J. Li, Y. Song, Y. Wang, J. Luo, and W. Yu MicroRNA-148a suppresses epithelial-to-mesenchymal transition by targeting ROCK1 in non-small cell lung cancer cells Mol. Cell. Biochem. 380 1-2 2013 277 282
11. I. Manaster, D. Goldman-Wohl, C. Greenfield, D. Nachmani, P. Tsukerman, Y. Hamani, S. Yagel, and O. Mandelboim miRNA-mediated control of HLA-G expression and function PLoS One 7 3 2012 e33395
12. G.B. da Silva, T.G. Silva, R.A. Duarte, N.L. Neto, H.H. Carrara, E.A. Donadi, M.A. Gonçalves, E.G. Soares, and C.P. Soares Expression of the classical and nonclassical HLA molecules in breast cancer Int. J. Breast Cancer 2013 2013 250435
13. O. Tchernitsa, A. Kasajima, R. Schafer, and R.J. Kuban Ation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression J. Pathol. 222 2010 310 319
14. R. Visone, L.Z. Rassenti, A. Veronese, C. Taccioli, S. Costinean, and B.D. Aguda Karyotype-specific microRNA signature in chronic lymphocytic leukemia Blood 114 2009 3872 3879
15. Y. Chen, Y. Song, Z. Wang, Z. Yue, H. Xu, and C. Xing Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance J. Gastrointest. Surg. 14 2010 1170 1179
16. R. Hummel, D.J. Hussey, M.Z. Michael, J. Haier, M. Bruewer, and N. Senninger MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma Ann. Surg. Oncol. 18 2011 253 260
17. S. Schwind, G. Marcucci, K. Maharry, M.D. Radmacher, K. Mrozek, and K.B. Holland BAALC and ERG expression levels are associated with out-come and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study Blood 116 2010 5660 5669
18. E. Aydoǧdu, A. Katchy, E. Tsouko, C.Y. Lin, L.A. Haldosén, L. Helguero, and C. Williams MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer Carcinogenesis 33 8 2012 1502 1511
19. H. Deng, X.T. Zhang, M.L. Wang, H.Y. Zheng, L.J. Liu, and Z.Y. Wang ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells PLoS One 9 2 2014 e88034
20. A.L. Scaling, E.R. Prossnitz, and H.J. Hathaway GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast Horm. Cancer 5 3 2014 146 160
21. I. Meneses-Morales, A.C. Tecalco-Cruz, T. Barrios-García, V. Gómez-Romero, I. Trujillo-González, S. Reyes-Carmona, E. García-Zepeda, E. Méndez-Enríquez, R. Cervantes- Roldán, V. Pérez-Sánchez, F. Recillas-Targa, A. Mohar-Betancourt, and A. León-Del-Río SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells Nucleic Acids Res. 2014 [Epub ahead of print]
22. M. Tamaki, Y. Konno, Y. Kobayashi, M. Takeda, M. Itoga, Y. Moritoki, H. Oyamada, H. Kayaba, J. Chihara, and S. Ueki Expression and functional roles of G-protein-coupled estrogen receptor (GPER) in human eosinophils Immunol. Lett. 160 1 2014 72 78
23. R. Lappano, A. Pisano, and M. Maggiolini GPER function in breast cancer: an overview Front. Endocrinol. 5 2014 66
24. Y. Yan, H. Liu, H. Wen, X. Jiang, X. Cao, G. Zhang, and G. Liu The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells Mol. Cell. Biochem. 378 1-2 2013 1 7
25. B. Zheng, L. Liang, C. Wang, S. Huang, X. Cao, R. Zha, L. Liu, D. Jia, Q. Tian, J. Wu, Y. Ye, Q. Wang, Z. Long, Y. Zhou, C. Du, X. He, and Y. Shi MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer Clin. Cancer Res. 17 24 2011 7574 7583
26. S.H. Wang, X. Li, L.S. Zhou, Z.W. Cao, C. Shi, C.Z. Zhou, Y.G. Wen, Y. Shen, and J.K. Li microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition Tumour Biol. 34 6 2013 3705 3712
27. Q. Xu, Y. Jiang, Y. Yin, Q. Li, J. He, Y. Jing, Y.T. Qi, Q. Xu, W. Li, B. Lu, S.S. Peiper, B.H. Jiang, and L.Z. Liu A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1 J. Mol. Cell. Biol. 5 1 2013 3 13
28. H. Liu, Y. Yan, H. Wen, X. Jiang, X. Cao, G. Zhang, and G. Liu A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells Cell Biol. Int. 38 5 2014 631 638
29. J. Steiman, E.A. Peralta, S. Louis, and O. Kamel Biology of the estrogen receptor, GPR30, in triple negative breast cancer Am. J. Surg. 206 5 2013 698 703
30. Z. Mo, M. Liu, F. Yang, H. Luo, Z. Li, G. Tu, and G. Yang GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer Breast Cancer Res. 15 6 2013 R114
31. H. Luo, G. Yang, T. Yu, S. Luo, C. Wu, Y. Sun, M. Liu, and G. Tu GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts Endocr. Relat. Cancer 21 2 2014 355 369
32. M. Sjöström, L. Hartman, D. Grabau, T. Fornander, P. Malmström, B. Nordenskjöld, D.C. Sgroi, L. Skoog, O. Stål, L.M. Leeb-Lundberg, and M. Fernö Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer Breast Cancer Res. Treat. 145 1 2014 61 71
33. T. Yu, M. Liu, H. Luo, C. Wu, X. Tang, S. Tang, P. Hu, Y. Yan, Z. Wang, and G. Tu GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells J. Steroid Biochem. Mol. Biol. 2014 pii: S0960-0760(14)00105-8
34. S. Jeong, S. Park, B.W. Park, Y. Park, O.J. Kwon, and H.S. Kim Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients PLoS One 9 5 2014 e98284
35. R.L. Elliott, X.P. Jiang, J.T. Phillips, B.G. Barnett, and J.F. Head Human leukocyte antigen G expression in breast cancer: role in immunosuppression Cancer Biother. Radiopharm. 26 2 2011 153 157